Zobrazeno 1 - 10
of 52
pro vyhledávání: '"heart failure with reduced left ventricular ejection fraction"'
Autor:
Kei Kawada, Tomoaki Ishida, Hitoshi Fukuda, Yuki Hyohdoh, Toru Kubo, Tomoyuki Hamada, Yuichi Baba, Toshinobu Hayashi, Fuka Aizawa, Kenta Yagi, Yuki Izawa-Ishizawa, Takahiro Niimura, Shinji Abe, Mitsuhiro Goda, Hiroaki Kitaoka, Keisuke Ishizawa
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionGuideline-directed medical therapy with renin-angiotensin system (RAS) inhibitors and beta-blockers has improved the survival of patients with heart failure (HF) and reduced left ventricular ejection fraction (HFrEF). However, it is uncle
Externí odkaz:
https://doaj.org/article/e34bac9ce74848e2895ccbfef15b579c
Autor:
Georgiy B. Mankovsky, Yevhen Yu. Marushko, Yanina A. Saienko, Ivanna V. Zubovych, Yana Yu. Dzhun, Olha O. Monashnenko, Nadiya M. Rudenko, Borys M. Mankovsky
Publikováno v:
Український журнал серцево-судинної хірургії, Vol 31, Iss 3, Pp 71-77 (2023)
Background. According to statistics, about 26 million people worldwide suffer from heart failure (HF). Currently, sodium-glucose cotransporter 2 inhibitors are widely prescribed for treatment of HF with reduced left ventricular ejec-tion fraction (LV
Externí odkaz:
https://doaj.org/article/0c3a3a39ea8c43fd9b376b00abea31a7
Autor:
Marta Bogowska, Aleksandra Berner, Klaudia Marczyk, Karolina Matyja, Anna Olszewska, Maciej Pękała, Paulina Polak, Monika Polaszek, Karina Stelmaszak, Katarzyna Stencel
Publikováno v:
Journal of Education, Health and Sport, Vol 38, Iss 1 (2023)
Inhibitors of the sodium-glucose cotransporter 2 (SGLT2 inhibitors) are relatively new and innovative antihyperglycemic drugs which by inhibiting sodium-glucose cotransporter 2 minimalise reabsorption of glucose in nephrones. Due to this process, SGL
Externí odkaz:
https://doaj.org/article/9edf471f11984c73b6462d331e787451
Autor:
Tamara A. Sakhnova, Elena V. Blinova, Elena S. Yurasova, Tatiana M. Uskach, Nataliya V. Blinova, Eduard A.I. Aidu, Vladimir G. Trunov, Marina A. Saidova
Publikováno v:
Терапевтический архив, Vol 94, Iss 9, Pp 1067-1071 (2022)
Aim. To explore the features of vectorcardiograms (VCG) of patients with essential hypertension complicated by chronic heart failure with reduced left ventricular ejection fraction (CHFrLVEF). Materials and methods. We analyzed VCGs of 70 hyperten
Externí odkaz:
https://doaj.org/article/ed5f39756e4241c68347a012eabaa850
Autor:
Alfiya A. Safiullina, Tatiana M. Uskach, Oleg V. Sapelnikov, Igor R. Grishin, Dmitrii I. Cherkashin, Valeriia A. Amanatova, Renat S. Akchurin, Sergey N. Tereshchenko
Publikováno v:
Терапевтический архив, Vol 94, Iss 9, Pp 1078-1084 (2022)
Aim. To evaluate the efficacy, safety and effect on the prognosis of cardiac contractility modulation (CCM) in patients with chronic heart failure (CHF) with reduced left ventricular ejection fraction and atrial fibrillation compared with the group o
Externí odkaz:
https://doaj.org/article/8ac5f5b6b827451aa196de365b7dd462
Publikováno v:
Український журнал серцево-судинної хірургії, Vol 30, Iss 3, Pp 44-49 (2022)
The aim. To evaluate the short-term and long-term outcomes of myocardial revascularization – percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) – in patients with coronary artery disease (CAD) and heart failure (H
Externí odkaz:
https://doaj.org/article/5be63593968e46a4bc5f995e80613028
Publikováno v:
Український журнал серцево-судинної хірургії, Vol 30, Iss 2, Pp 51-58 (2022)
The aim. To evaluate clinical and prognostic effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on primary (progression of heart failure, rehospitalization) and secondary endpoints (death from cardiovascular disease and from all causes) in
Externí odkaz:
https://doaj.org/article/568bb98966174668a3476b92f3033b2b
Autor:
Jadwiga Nessler
Publikováno v:
Advances in Interventional Cardiology, Vol 17, Iss 2, Pp 135-140 (2021)
Because of its frequent occurrence, poor prognosis, low quality of life of patients accompanying the disease and high costs associated with treatment heart failure is a significant health problem in modern cardiology. The treatment of patients with h
Externí odkaz:
https://doaj.org/article/7df11093d00449928650f3e7ff95d42c
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Heart failure (HF) is a challenging situation in healthcare worldwide. Secondary mitral regurgitation (SMR) is a common condition in HF patients with reduced ejection fraction (HFrEF) and tends to be increasingly associated with unfavorable clinical
Externí odkaz:
https://doaj.org/article/cf261e7a7c6b46a7b7a7da3d31350266
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.